PAT-derived LPE18:1 promotes ccRCC progression by inducing #LipidReprogramming, thus positioning the CAPZA1/USP48/SIRT6 axis as an actionable #TherapeuticTarget for metabolic malignancies.

#STTT #OpenAccess: doi.org/10.1038/s413...